HIGHLIGHTS
- who: Immunotherapy A Screening Tool and colleagues from the USA Medical Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, USA have published the paper: Review began 06/22/2022 Review ended 07/01/2022 Published 07/14/2022 u00a9 Copyright, in the Journal: (JOURNAL) of July/14,/2022
- what: The authors noted an improvement in the comfort levels of oncology providers in diagnosing and managing these complications. While the screening tool is easy to follow and can be easily adapted to the needs of any healthcare facility, the study has several limitations. The . . .

If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.